je.st
news
Home
› DPx Launches As Global Provider Of Pharmaceutical Services, Fine Chemicals And Proprietary Technologies
DPx Launches As Global Provider Of Pharmaceutical Services, Fine Chemicals And Proprietary Technologies
2014-03-12 02:59:10| drugdiscoveryonline News Articles
DPx Holdings B.V. (DPx), privately owned by JLL Partners and Royal DSM, recently launched as a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.
Tags: services
global
fine
technologies
Category:Biotechnology and Pharmaceuticals